-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Assumes Verrica Pharmaceuticals at Buy, Announces Price Target of $12

Benzinga·05/26/2026 10:51:11
Listen to the news
HC Wainwright & Co. analyst Raghuram Selvaraju assumes Verrica Pharmaceuticals (NASDAQ:VRCA) with a Buy rating and announces Price Target of $12.